AKI Therapeutics A/S: Financial statements 2020
CVR: 37509736
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AKI Therapeutics A/S (CVR 37509736) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -89,304 and a net result of DKK 148,172 compared with DKK 27,968 the year before. Equity in the 2020 report amounted to DKK 115,247. The solvency ratio was 6%.
- Gross Profit
- DKK -89,304
- Profit/Loss
- DKK 148,172
- Equity
- DKK 115,247
- Total Assets
- DKK 1,930,889
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -89K | 148K | 115K | - |
| 2019 | - | -127K | 28K | 52K | - |
| 2018 | - | -5K | -5K | 24K | - |
| 2017 | - | -4K | -13K | 29K | - |
| 2016 | - | -7K | -8K | 42K | - |
Official annual report
How creditworthy is AKI Therapeutics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 28, 2020, Sigbjørn Georg Nielsen Kjærgård is registered as director of AKI Therapeutics A/S.
As of September 28, 2020, Torsten Bjørn has stepped down as director of AKI Therapeutics A/S.
AKI Therapeutics A/S has published its annual report for 2019. Gross profit came to DKK -127,150, and the net result was DKK 27,968.
As of September 1, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of AKI Therapeutics A/S.
As of September 1, 2020, KALLERMANN REVISION A/S STATSAUTORISERET REVISIONSFIRMA has stepped down as auditor of AKI Therapeutics A/S.
As of August 17, 2020, BREGNERØDVEJ AUTO ApS is registered as an owner of AKI Therapeutics A/S with an ownership share of 5%.
About AKI Therapeutics A/S
AKI Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named AKI Therapeutics ApS and Renoguard ApS. The management consists of Sigbjørn Georg Nielsen Kjærgård. The board consists of Charlotte Pahl, Christian Vinding Thomsen and Lars Otto Uttenthal. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,593,852,000 compared with DKK -1,960,091 the year before. Equity in the 2025 report amounted to DKK 551,898,000.